Two Patients Suits Filed By The Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Against Gilead

747

Dallas, Texas 12/09/2013 (Financialstrend) – Recently Idenix Pharmaceuticals Inc (NASDAQ:IDIX) declared that it has lodged 2 different patient lawsuits against the Gilead Sciences. The first one is a patent violation claim in Boston, Massachusetts at the United States District Court and the second one is a patent infringement and interference lawsuit in Wilmington, Delaware at the United States District Court.

The first lawsuit says that Gilead has infringed two US patents which are owned by the Idenix Pharma, for treating the hepatitis C virus using 2′-methyl nucleosides. Moreover the Idenix Pharma is also trying to make Gilead declare that it is distributing, importing, using and selling drug containing sofosbuvir which is a 2-methyl nucleoside compound which infringes with Idenix patents.

The second lawsuit filed at Delaware, United States District Court states that Gilead infringes another separate US patent owned by Idenix that covers different methods of treating hepatitis C virus using 2′-methyl-2′-fluoro nucleosides.

Some more ongoing patent disputes

Apart from the above said lawsuits there are some more lawsuits that have been filed by the Idenix against the Gilead such as pending Idenix patent application which covers certain 2′- methyl, 2′- fluoro nucleoside compounds with another patent granted to Gilead. It is also related to certain 2′- methyl, 2′- fluoro nucleoside compounds.

But Gilead has also attacked them back by filing a lawsuit against Idenix to invalidate the patents being granted to Idenix for addressing some 2′-methyl-2′-fluoro nucleoside compounds and their utilization in dealing HCV or other Flaviviridae viruses.

Idenix Pharmaceuticals Inc (NASDAQ:IDIX) is a firm that is headquartered in Massachusetts and is a major biopharma company that discovers and develops medicines for the cure of different human viral diseases. The current and most talked about project is the treatment of patients with hepatitis C infection and some more dream projects.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.